# Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer

> **NCT02681432** · PHASE3 · UNKNOWN · sponsor: **PEDRO VILLAREJO CAMPOS** · enrollment: 60 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer

## Interventions

- **DRUG:** HIPEC
- **PROCEDURE:** No HIPEC

## Key facts

- **NCT ID:** NCT02681432
- **Lead sponsor:** PEDRO VILLAREJO CAMPOS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2019-09
- **Final completion:** 2019-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02681432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02681432, "Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02681432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*